Loss of MEG3 Contributes to the Enhanced Migration and Invasion in Arsenic-induced Carcinogenesis Through NQO1/FSCN1 Pathway

Overview

Journal Am J Cancer Res

Specialty Oncology

Date 2023 Jul 10

PMID 37424815

Authors

Huailu Tu

Zhuo Zhang

Jingxia Li

Sophia Shi

Max Costa

Affiliations

Soon will be listed here.

Abstract

Arsenic ranks at the top among all toxic metals and poses a serious threat to human health. Inorganic arsenite and arsenate compounds have been classified as human carcinogens in various types of cancers. Maternally expressed gene 3 (MEG3), a tumor suppressor that is commonly lost in cancer, was investigated in this study for its role in the migration and invasion of arsenic-transformed cells. Our results showed that MEG3 was downregulated in both arsenic-transformed cells (As-T) and cells treated with low doses of arsenic for three months (As-treated). The analysis using TCGA dataset revealed that MEG3 expression was significantly reduced in the tumor tissues from human lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) compared to normal lung tissues. The results from the methylation-specific PCR (MSP) assay demonstrated enhanced methylation in the MEG3 promoters in both As-T and As-treated cells, indicating that increased methylation of the MEG3 promoter caused MEG3 downregulation in these cells. Moreover, As-T cells displayed increased migration and invasion and higher levels of NAD(P)H quinone dehydrogenase 1 (NQO1) and fascin actin-bundling protein 1 (FSCN1). Consistently, the results from immunohistochemistry staining showed that both NQO1 and FSCN1 are highly expressed in human lung squamous cell carcinoma tissues compared to those in normal lungs. Knockdown of MEG3 in normal BEAS-2B cells also led to increased migration and invasion, along with elevated levels of NQO1 and FSCN1. The negative regulation of MEG3 on FSCN1 was restored by NQO1 overexpression in both As-T and BEAS-2B cells. The results from immunoprecipitation assays confirmed the direct binding of NQO1 to FSCN1. Overexpression of NQO1 increased migration and invasion abilities in BEAS-2B cells, while knockdown of NQO1 by its shRNA reduced these two hallmarks of cancer. Interestingly, the reduced migration and invasion by NQO1 knockdown were restored by FSCN1. Collectively, the loss of MEG3 upregulated NQO1, which in turn stabilized FSCN1 protein through its direct binding, resulting in elevated migration and invasion in arsenic-transformed cells.

Citing Articles

Dysregulation of Long Non-coding RNAs-the Novel lnc in Metal Toxicity and Carcinogenesis.

Wang Z, Wang P, Yang C Curr Environ Health Rep. 2024; 12(1):3.

PMID: 39715843 PMC: 11755759. DOI: 10.1007/s40572-024-00468-1.

Isorhapontigenin (ISO) inhibits malignant cell transformation, migration, and invasion through MEG3/NEDD9 signaling in Cr(VI)-transformed cells.

Shi S, Li J, Zhang Z, Tu H, Max C Toxicol Appl Pharmacol. 2023; 476:116661.

PMID: 37619952 PMC: 10874125. DOI: 10.1016/j.taap.2023.116661.

References

Huang C, Liao X, Jin H, Xie F, Zheng F, Li J . MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion. Mol Ther Nucleic Acids. 2019; 16:51-62. PMC: 6396102. DOI: 10.1016/j.omtn.2019.01.014. View

Oh E, Kim J, Kim J, Kim S, Lee J, Hong S . NQO1 inhibits proteasome-mediated degradation of HIF-1α. Nat Commun. 2016; 7:13593. PMC: 5171868. DOI: 10.1038/ncomms13593. View

Gao Y, Huang P, Zhang J . Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma. J Transl Med. 2017; 15(1):268. PMC: 5747938. DOI: 10.1186/s12967-017-1372-8. View

Dinkova-Kostova A, Talalay P . NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys. 2010; 501(1):116-23. PMC: 2930038. DOI: 10.1016/j.abb.2010.03.019. View

Wei S, Zhang H, Tao S . A review of arsenic exposure and lung cancer. Toxicol Res (Camb). 2019; 8(3):319-327. PMC: 6505385. DOI: 10.1039/c8tx00298c. View

Moon K, Guallar E, Navas-Acien A . Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep. 2012; 14(6):542-55. PMC: 3483370. DOI: 10.1007/s11883-012-0280-x. View

Zhou Y, Zhong Y, Wang Y, Zhang X, Batista D, Gejman R . Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 2007; 282(34):24731-42. DOI: 10.1074/jbc.M702029200. View

Zhu J, Liu S, Ye F, Shen Y, Tie Y, Zhu J . Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells. PLoS One. 2015; 10(10):e0139790. PMC: 4596861. DOI: 10.1371/journal.pone.0139790. View

Khan K, Chakraborty R, Bundschuh J, Bhattacharya P, Parvez F . Health effects of arsenic exposure in Latin America: An overview of the past eight years of research. Sci Total Environ. 2020; 710:136071. PMC: 7063974. DOI: 10.1016/j.scitotenv.2019.136071. View

10.

Li H, Wang F, Shan L, An J, Liu M, Li W . Comprehensive analysis of gene expression and DNA methylation for human nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol. 2019; 276(9):2565-2576. DOI: 10.1007/s00405-019-05525-2. View

11.

Zhao X, Gao S, Ren H, Sun W, Zhang H, Sun J . Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Cancer Res. 2014; 74(9):2455-64. DOI: 10.1158/0008-5472.CAN-13-3009. View

12.

Zhang Z, Li J, Yan B, Tu H, Huang C, Costa M . Loss of MEG3 and upregulation of miR-145 play an important role in the invasion and migration of Cr(VI)-transformed cells. Heliyon. 2022; 8(8):e10086. PMC: 9421329. DOI: 10.1016/j.heliyon.2022.e10086. View

13.

Adams J . Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol. 2004; 16(5):590-6. DOI: 10.1016/j.ceb.2004.07.009. View

14.

Wang C, Li Y, Huang B, Zhao Y, Yuan H, Guo D . EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer. Sci Rep. 2017; 7(1):15654. PMC: 5688137. DOI: 10.1038/s41598-017-15939-9. View

15.

Qin N, Tong G, Sun L, Xu X . Long Noncoding RNA MEG3 Suppresses Glioma Cell Proliferation, Migration, and Invasion by Acting as a Competing Endogenous RNA of miR-19a. Oncol Res. 2017; 25(9):1471-1478. PMC: 7841124. DOI: 10.3727/096504017X14886689179993. View

16.

Rahman M, Vahter M, Wahed M, Sohel N, Yunus M, Streatfield P . Prevalence of arsenic exposure and skin lesions. A population based survey in Matlab, Bangladesh. J Epidemiol Community Health. 2006; 60(3):242-8. PMC: 2465558. DOI: 10.1136/jech.2005.040212. View

17.

He C, Yang W, Yang J, Ding J, Li S, Wu H . Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells. DNA Cell Biol. 2017; 36(6):475-481. DOI: 10.1089/dna.2017.3682. View

18.

Chen Y, Tian T, Li Z, Wang C, Deng R, Deng W . FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma. Cell Death Dis. 2019; 10(5):356. PMC: 6494834. DOI: 10.1038/s41419-019-1574-5. View

19.

Wang C, Tang C, Wang Y, Jin L, Wang Q, Li X . FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer. Sci Rep. 2017; 7(1):15887. PMC: 5698288. DOI: 10.1038/s41598-017-16196-6. View

20.

Vahter M . Health effects of early life exposure to arsenic. Basic Clin Pharmacol Toxicol. 2008; 102(2):204-11. DOI: 10.1111/j.1742-7843.2007.00168.x. View